Increased systemic HSP70B levels in spinal muscular atrophy infants

Despite newly available treatments for spinal muscular atrophy (SMA), novel circulating biomarkers are still critically necessary to track SMA progression and therapeutic response. To identify potential biomarkers, we performed whole‐blood RNA sequencing analysis in SMA type 1 subjects under 1 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichelberger, Eric J., Alves, Christiano R. R., Zhang, Ren, Petrillo, Marco, Cullen, Patrick, Farwell, Wildon, Hurt, Jessica A., Staropoli, John F., Swoboda, Kathryn J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283166/
https://www.ncbi.nlm.nih.gov/pubmed/33991176
http://dx.doi.org/10.1002/acn3.51377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283166/
https://www.ncbi.nlm.nih.gov/pubmed/33991176
http://dx.doi.org/10.1002/acn3.51377

Ejemplares similares